Development of HDAC Inhibitors Exhibiting Therapeutic Potential in T-Cell Prolymphocytic Leukemia

Krimo Toutah, Nabanita Nawar, Sanna Timonen, Helena Sorger, Yasir S. Raouf, Shazreh Bukhari, Jana von Jan, Aleksandr Ianevski, Justyna M. Gawel, Olasunkanmi O. Olaoye, Mulu Geletu, Ayah Abdeldayem, Johan Israelian, Tudor B. Radu, Abootaleb Sedighi, Muzaffar N. Bhatti, Muhammad Murtaza Hassan, Pimyupa Manaswiyoungkul, Andrew E. Shouksmith, Heidi A. NeubauerElvin D. de Araujo, Tero Aittokallio, Oliver H. Kraemer, Richard Moriggl, Satu Mustjoki, Marco Herling, Patrick T. Gunning

Research output: Contribution to journalArticleScientificpeer-review

Original languageEnglish
JournalJournal of Medicinal Chemistry
Volume64
Issue number12
Pages (from-to)8486-8509
Number of pages24
ISSN0022-2623
DOIs
Publication statusPublished - 24 Jun 2021
MoE publication typeA1 Journal article-refereed

Fields of Science

  • HISTONE DEACETYLASE INHIBITOR
  • SUBEROYLANILIDE HYDROXAMIC ACID
  • ACCURATE DOCKING
  • BCL-2 INHIBITOR
  • TUBULIN
  • RICOLINOSTAT
  • COMBINATION
  • EXPRESSION
  • BORTEZOMIB
  • MODEL
  • 3122 Cancers

Cite this